GlassScriptPhysician profile
Xiaogang Jiang
NPI 1376809566
$3,775.51
in general payments reported to CMS, 2019-2025
19 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.35 · 2020: $143 · 2021: $210 · 2022: $215 · 2023: $2,627 · 2024: $185 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,691 · Food and Beverage: $1,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,691.31 |
| Food and Beverage | $1,432.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,767.97 | 2021-2023 | Intellis Adaptivestim |
| Bioventus LLC | $665.00 | 2023-2024 | Stimrouter Implantable Kit, Stimrouter Implantable Kit |
| Nevro Corp. | $374.88 | 2022-2024 | Senza |
| Si-Bone, INC. | $326.11 | 2019-2025 | |
| Spr Therapeutics, INC | $162.31 | 2022-2025 | Sprint Pns System |
| Globus Medical, INC. | $155.08 | 2025 | Senza |
| Allergan, INC. | $63.17 | 2019-2020 | |
| Boston Scientific Corporation | $46.78 | 2023-2024 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Abbott Laboratories | $39.46 | 2022-2025 | Eterna |
| Arbor Pharmaceuticals, INC. | $30.14 | 2019-2020 | |
| Avanos Medical | $20.79 | 2023 | Coolief* Cooled Radiofrequency |
| Amgen INC. | $19.16 | 2020 | |
| Zealand Pharma US, INC. | $16.92 | 2021 | |
| Novo Nordisk INC | $16.55 | 2020 | |
| Lilly USA, LLC | $15.74 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $15.65 | 2019 | |
| Pfizer INC. | $14.69 | 2019 | |
| Biodelivery Sciences International, INC. | $12.57 | 2021 | |
| Zyla Life Sciences, INC. | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaogang Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.